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Cisplatin-induced inhibition of receptor-mediated endocytosis of human malignancies. A number of studies have exam-
of protein in the kidney. ined the effects of this drug on the renal structure and
Background. Administration of cisplatin, cis-diamminedi- biochemical functions using both human and animal mod-chloroplatinum (II) (CDDP), causes a severe impairment of
els [1–3]. In rats treated with a single dose of CDDP,renal function, including increases in urinary excretion of
sodium wasting and glucosuria appeared at an early stageproteins. We recently found that CDDP inhibits vacuolar H-
ATPase, which plays an important role in receptor-mediated [3–5]. Recently, it has become clear that CDDP interferes
endocytosis in the renal proximal tubules. Therefore, CDDP- directly with transporters for water, electrolytes and nu-
induced proteinuria may be due to an inhibition of the receptor- trients in renal tubular epithelia [6–8]. In addition, increasesmediated endocytosis in the renal proximal tubules following
in urinary excretion of plasma proteins such as 2 micro-a decrease in vacuolar H-ATPase activity by the drug.
globulin and albumin by CDDP administration have beenMethods. Effects of CDDP on receptor-mediated endocyto-
sis of albumin in opossum kidney (OK) epithelial cells, and on observed [9, 10]. However, the mechanism by which CDDP
urinary excretion of albumin and vitamin D binding protein, administration induces proteinuria remains unclear.
which are reabsorbed in the renal proximal tubules by endocy- Most of plasma proteins and several hormones filteredtosis, in rats were examined.
in the glomerulus are reabsorbed in the renal proximalResults. CDDP inhibited uptake of fluorescein-isothiocya-
tubules by receptor-mediated endocytosis [11, 12]. Sev-nate (FITC)-albumin, a receptor-mediated endocytosis marker,
by OK cells in a time- and concentration-dependent fashion. eral reports indicate that receptor-mediated endocytosis
In contrast, CDDP treatment did not affect the uptake of FITC- in the renal proximal tubules is regulated by the compo-
inulin, a fluid-phase endocytosis marker. CDDP caused a de- nents of the acidification machinery including vacuolarcrease in the affinity and in the maximal velocity of FITC-
type proton-translocating adenosine 5-triphosphatasealbumin uptake. The adenosine 5-triphosphate (ATP) content
(vacuolar H-ATPase) and chloride channel, ClC-5 [11,in OK cells was not changed by CDDP at concentrations that
inhibited FITC-albumin uptake. The endosomal pH in OK 13, 14]. These components are involved in the formation
cells was increased by CDDP treatment. Administration of of the proton gradient and the maintenance of electro-
CDDP to rats increased the urinary excretion of albumin and neutrality in the endosome. Acidification of the endo-vitamin D binding protein.
somes plays a crucial role in the sorting of internalizedConclusions. These results suggest that CDDP decreases the
ligands, receptors, and solutes in intracellular traffickingreceptor-mediated endocytosis of protein following the inhibi-
tion of vacuolar H-ATPase in the renal proximal tubules, and in the renal proximal tubules under physiological condi-
the inhibition of receptor-mediated endocytosis would be the tions [11, 15]. Therefore, a change in the activities of
mechanisms underlying the proteinuria induced by CDDP. vacuolar H-ATPase and chloride channel could affect
the overall process of receptor-mediated endocytosis.
CDDP affects the activities of various proteins having
Nephrotoxicity is one of the most significant adverse sulfhydryl groups essential for their functions. CDDP-
effects of cisplatin, cis-diamminedichloroplatinum (II) induced inhibition of Na/glucose cotransport system
(CDDP), a very potent drug used to treat a wide variety could result from covalent platinum binding to sulfhydryl
groups of the transporter. Vacuolar H-ATPase also
possesses sulfhydryl groups that are essential for its activ-Key words: proteinuria, tubular reabsorption, albumin, vitamin D bind-
ing protein, vacuolar H-ATPase, carboplatin. ity, as it has been reported that vacuolar H-ATPase is
inhibited by a disulfide bond formation between twoReceived for publication August 15, 2001
conserved cysteine residues (Cys-254 and Cys-532) lo-and in revised form June 10, 2002
Accepted for publication June 18, 2002 cated at the catalytic site on the 73-kD A subunit [16, 17].
We recently observed a decrease in vacuolar H-ATPase 2002 by the International Society of Nephrology
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activity in renal brush border membranes prepared from taining FITC-albumin or FITC-inulin was added to each
dish and the cells were incubated at 37C for a specifiedCDDP-administered rats [18]. In addition, CDDP di-
rectly inhibited vacuolar H-ATPase when brush border period. At the end of the incubation, the uptake buffer
was aspirated and the dishes were rinsed rapidly threemembranes from control rats were treated with CDDP
in vitro [18]. Based on these findings, we speculated times with 1 mL of ice-cold PBS buffer. The cells were
scraped with rubber policeman into 1 mL of ice-coldthat decrease in vacuolar H-ATPase activity could be
involved in CDDP-induced renal tubular dysfunctions PBS buffer and the dishes were rinsed again with 1 mL
of ice-cold PBS buffer to improve the recovery of thesuch as proteinuria and proximal tubular acidosis [18].
In order to clarify the mechanism by which CDDP cells. The cells were centrifuged at 4C for five minutes
at 1000 rpm and the supernatant was aspirated. The cellcauses proteinuria, we studied the effects of CDDP on
the receptor-mediated endocytosis in opossum kidney pellet was resuspended gently in 1 mL of ice-cold PBS
buffer and centrifuged again. The pellet was homoge-(OK) cells, which is a suitable model to study endocytosis
in the renal proximal tubules [14, 19, 20]. In addition, nized in PBS buffer containing 0.1% Triton X-100 (vol/
vol), and the homogenate was used for fluorescence andwe examined whether CDDP administration to rats in-
creases the urinary excretion of albumin and vitamin D protein assays. The intracellular fluorescence was mea-
sured by using a Hitachi fluorescence spectrophotometerbinding protein in vivo; the latter is a substrate for the
endocytic receptor megalin expressed in the renal proxi- F-3000 (Tokyo, Japan) at an excitation wavelength of
500 nm and an emission wavelength of 520 nm. Proteinmal tubule epithelium [21, 22].
was determined by the method of Lowry et al [24] with
bovine serum albumin as the standard.
METHODS
Materials Cell treatment
To expose the OK cell monolayers to CDDP andCDDP, cis-diammine-1,1-cyclobutanedicarboxylate
platinum (carboplatin, CBDCA), fluorescein-isothiocya- CBDCA, the cells were incubated in culture medium
containing each compound for a specified period at 37C.nate (FITC)-labeled bovine serum albumin (FITC-albu-
min) and FITC-labeled inulin (FITC-inulin) were pur- The control cells were incubated in culture medium con-
taining the same volume of saline in each experiment.chased from Sigma Chemical Co. (St. Louis, MO, USA).
Blood urea nitrogen (BUN) assay kit was obtained from Finally, the cell monolayers were washed three times
with PBS buffer before measuring uptake of FITC-albu-Wako Pure Chemicals (Osaka, Japan). The N-acetyl--
d-glucosaminidase (NAG) assay kit was from Shionogi min and FITC-inulin.
and Co. (Osaka, Japan). All other chemicals used were
Lactate dehydrogenase assayof the highest purity available.
Lactate dehydrogenase (LDH) activities in the culture
Cell culture medium and in the cells were determined. To measure
LDH activity in the OK cells, the monolayer of cells wasOpossum kidney cells were cultured in medium 199
(Gibco BRL, Life Technologies, NY, USA) containing washed with ice-cold PBS buffer without calcium and
magnesium [PBS() buffer]. Then, the cells were lysed10% fetal bovine serum (FBS; Biological Industries, Bet
Haemek, Israel) without antibiotics, in an atmosphere with 0.1% Triton X-100 in PBS() buffer. The medium
and cell lysate were centrifuged at 11,150 g for 1.5 min-of 5% CO2-95% air at 37C, and subcultured every seven
days using 0.02% ethylenediaminetetraacetic acid (EDTA) utes. The LDH activity in the supernatant was measured
with a commercial kit available from Wako Pure Chemi-and 0.05% trypsin [23]. OK cells were used between
passages 86 and 96. cals (Osaka, Japan).
Determination of intracellular ATP contentUptake study
Uptake of FITC-albumin and FITC-inulin was mea- The intracellular ATP content in OK cells and in rat
renal cortex was measured as described by Hori et alsured in OK cells attached to the culture dishes (35-mm)
as described previously [14]. Briefly, fresh medium was [25]. Briefly, in OK cells, the cells grown in the 100-mm
dishes were rapidly washed three times with 5 mL ofreplaced every two or three days, and the cells were used
on the fifth or sixth day after seeding. Experiments were ice-cold PBS buffer and treated with 1 mL of ice-cold 3%
perchloric acid, and the cells were scraped with rubberperformed in Dulbecco’s phosphate-buffered saline (PBS
buffer containing in mmol/L, 137 NaCl, 3 KCl, 8 Na2HPO4, policeman. In rat, the renal cortex was prepared by the
use of a Stadie-Riggs microtome. After the wet weight1.5 KH2PO4, 1 CaCl2 and 0.5 MgCl2) supplemented with
5 mmol/L d-glucose [PBS(G) buffer]. After removal of was measured, the renal cortex was homogenized with
4 volumes of ice-cold 3% perchloric acid. After centrifu-the culture medium, each dish was washed and preincu-
bated with PBS (G) buffer. Then, PBS (G) buffer con- gation of the OK cell suspension and the renal cortical
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homogenate at 3000 rpm for 15 minutes, the supernatant Chemical Co.). After the plates were left covered at 4C,
the wells were washed in washing buffer [0.9% NaCl (wt/was neutralized with 0.6 mol/L KOH and was used to
determine ATP enzymatically with hexokinase and glu- vol), 0.05% Tween 20 (vol/vol)] and 100 L of the stan-
dard rat serum albumin and urine samples, which werecose-6-phosphate dehydrogenase.
diluted with incubation buffer [50 mmol/L phosphate
Determination of endosomal pH buffer, pH 7.5, 150 mmol/L NaCl, 0.05% Tween 20 (vol/
vol)], were added to the wells. Then, 100 L of the rabbitOpossum kidney cells were seeded on thin glass micro-
scope coverslips. Five days after plating, at which time horseradish peroxidase-conjugated anti-rat albumin im-
munoglobulin (Nordic Immunological Laboratories, Til-the cells reached confluence, they were pretreated with-
out or with CDDP (50mol/L) or CBDCA (300mol/L) burg, Netherlands) diluted 1:5000 in the incubation
buffer was added to the same wells. The mixture in thefor 24 hours, and the endosomal pH was determined
fluorimetrically by a modification of the methods of Oh- wells was incubated at room temperature for three hours.
After washing three times with the washing buffer, 100 Lkuma and Poole [26] and Gekle et al [13]. Briefly, the
cell monolayers on the glass coverslips were incubated of substrate solution [0.1 mol/L citrate-phosphate buffer,
pH 5.1, containing 0.1% o-phenylenediamine (wt/vol),with FITC-albumin (1 mg/mL) for 10 minutes at 37C,
and then the cells were washed ten times with PBS(G) 0.01% H2O2 (vol/vol)] was added and incubated at room
temperature for 20 minutes. Color development was ter-buffer and the coverslip was mounted in the holding de-
vice of a Hitachi fluorescence spectrophotometer F-3000. minated by the addition of 100 L of 2 mol/L H2SO4 per
well, and the absorbance was measured at 492 nm withThe coverslip was aligned at 30 to the excitation beam to
minimize the effect of light reflections [26]. Five minutes a VERSAmax tunable microplate reader (Molecular
Devices Co., Sunnyvale, CA, USA).after washing the cells, the intensity ratio of fluorescence
was measured at 37C with excitation at 485 nm to that
Detection of vitamin D binding protein in urinewith excitation at 436 nm. Emission in two excitation
by Western blot analysiswavelengths was measured at 519 nm. The intensity ra-
tios of calibration solutions titrated to pH 5.42, 5.49, 5.93, The collected urine was dialyzed by use of cellulose
membrane and was concentrated by freeze-drying. The6.47, 6.97, 7.38 and 7.51 were measured, and the obtained
values were fitted by the least-squares method to the pellet was solubilized in a loading buffer; 2% SDS,
62.5 mmol/L Tris-HCl, 7% glycerol with 5% 2-mercapto-equation R  a · pH  b, where R is the calculated
ratio, a is the slope and b is the intercept with y-axis. ethanol. The sample was subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)The estimated calibration curve was used for conversion
of calculated ratios to endosomal pH. with 10% polyacrylamide gels. The proteins were trans-
ferred for 60 minutes to polyvinylidene difluoride (PVDF)
Animal experiment membrane (Immun-Blot; Bio-Rad Laboratories, Hercu-
les, CA, USA) at 4C. The membrane was blocked inMale Wistar rats (260 to 290 g) received a bolus in-
traperitoneal administration of saline (normal group), 5% non-fat dry milk in Tris-buffered saline (TBS; 150
mmol/L NaCl, 20 mmol/L Tris-HCl, pH 7.5) with 0.05%CDDP (5 mg/kg) or CBDCA (80 mg/kg). After the ad-
ministration, each rat was placed in a metabolic cage to Tween 20 (TBS-T) overnight at 4C. The membrane was
washed three times for 10 minutes in TBS-T, and wascollect a 24-hour urine sample at a stated day. All ex-
periments with animals were performed in accordance incubated with anti-human vitamin D binding protein
rabbit antiserum (1:500 dilution) purchased from Dakowith the Guide for Animal Experimentation, Hiroshima
University and the Committee of Research Facilities for Japan (Kyoto, Japan). The membrane was washed three
times, and was incubated with the horseradish peroxi-Laboratory Animal Sciences, Faculty of Medicine, Hiro-
shima University. dase-conjugated anti-rabbit immunoglobulin (1:2000 di-
lution; ICN Pharmaceuticals Inc., Aurola, OH, USA) as
Quantification of BUN and urinary NAG a secondary antibody, washed again three times in TBS-T,
and albumin and visualized with enhanced chemiluminescence (ECL;
Amersham Pharmacia Biotech, Buckinghamshire, UK).Blood urea nitrogen and urinary NAG were measured
spectrophotometrically using a commercially available The optical density for each vitamin D binding protein
band was determined by the public domain Internet pro-kit. The urinary albumin was determined by a modifica-
tion of the simplified enzyme-linked immunosorbent gram, NIH image (Bethesda, MD, USA).
assay (ELISA) reported by Torffvit and Wieslander [27].
Western blot analysis for megalin andBriefly, polyvinyl chloride flexible 96-well plates (Falcon
ClC-5 in renal cortex3911; Becton Dickinson, Franklin Lakes, NJ, USA) were
coated with 200 L of coating buffer (50 mmol/L Na2CO3, Rat renal cortex was prepared by the use of a Stadie-
Riggs microtome, and then the cortex was homogenizedpH 9.6) containing 0.1 mg/L rat serum albumin (Sigma
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Fig. 1. Effects of CDDP pretreatment time on FITC-albumin uptake
in OK cells. Confluent monolayers of OK cells were incubated in the
Fig. 2. Concentration-dependent effect of CDDP on FITC-albuminabsence (control;) or presence () of CDDP (50 mol/L) for various
uptake in OK cells. Confluent monolayers of OK cells were incubatedperiods (3-24 hours), and uptake of FITC-albumin (30 g/mL) for 30
for 24 hours without (control; ) or with various () concentrationsminutes was measured at 37C. Each point is the mean 	 SE of three
of CDDP (0.3 to 50 mol/L), and uptake of FITC-albumin (30 g/mL)to four monolayers. *P 
 0.05, significant difference from control.
for 30 minutes was measured at 37C. Each point is the mean 	 SE of
three to six monolayers. *P 
 0.05, significant difference from control.
for two minutes with an IKA T25 Basic disperser (IKA
LABORTECHNIK, Staufen, Germany) in an ice-cold Statistical analysis
buffer (150 mmol/L NaCl, 1 mmol/L, EDTA, 1 mmol/L
Statistical analysis was performed by the Student t test,PMSF with 20 mmol/L Tris, pH 7.4), and were subse-
or by the one way analysis of variance (ANOVA) withquently homogenized with a glass/Teflon Potter homoge-
the Scheffe´ test for post hoc analysis (P 
 0.05 for sig-nizer with 10 strokes at 1000 rpm. The homogenate was
nificance).centrifuged at 3000  g for 10 minutes at 4C in an
Avanti 30 Compact Centrifuge with rotor F0630. The
supernatant was centrifuged at 40,000 g for 30 minutes RESULTS
at 4C. The pellet was resupended in the ice-cold buffer
Effect of CDDP and CBDCA on endocytic uptakecontaining 1% Triton X-100, and centrifuged at 14,000
in OK cellsg for 15 minutes at 4C. The supernatant, which contains
Figure 1 shows the effect of CDDP pretreatment timecrude membrane fractions of the renal cortex, was heated
(3 to 24 hours) on the uptake of FITC-albumin, a markerfor five minutes at 95C in a loading buffer. These sam-
for receptor-mediated endocytosis, in OK kidney epithe-ples were subjected to SDS-PAGE with 6% (for mega-
lial cell monolayers. Exposure to CDDP caused a time-lin) or 10% (for ClC-5) polyacrylamide gels, and the
dependent decrease in the uptake of FITC-albumin, andproteins were transferred for 60 minutes to a PVDF
it was significant at 12 hours or later. The effect of variousmembrane at 4C. The membrane was blocked in 5%
concentrations of CDDP on the uptake of FITC-albuminnon-fat dry milk in TBS-T overnight at 4C. The mem-
was examined in OK cells. OK cells were pretreatedbranes were washed three times for 10 minutes in TBS-T,
with various concentrations (0.3 to 50 mol/L) of CDDPand were incubated with the anti-rat megalin rabbit anti-
for 24 hours, then the FITC-albumin uptake was mea-serum (1:5000 dilution) [22] or the anti-rat ClC-5 rabbit
sured. As shown in Figure 2, CDDP inhibited the uptakeantiserum (1:5000 dilution) [14]. The membranes were
of FITC-albumin in a concentration-dependent manner,washed three times in TBS-T, and were incubated with
and it was significant at 10mol/L or higher. An apparentthe horseradish peroxidase-conjugated anti-rabbit IgG
half-maximal inhibitory concentration (IC50) of CDDPantibody (1: 2000 dilution), washed three times in TBS-T,
and visualized with ECL. was 11.3 mol/L. We also examined the effect of various
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Fig. 4. Effects of CDDP on FITC-inulin uptake in OK cells. Confluent
monolayers of OK cells were incubated for 24 hours without () or
with () various concentrations of CDDP (0.3 to 50 mol/L), andFig. 3. Concentration-dependent effect of CBDCA on FITC-albumin
uptake of FITC-inulin (500 g/mL) for 30 minutes was measured atuptake in OK cells. Confluent monolayers of OK cells were incubated
37C. Each point is the mean 	 SE of three to four monolayers.for 24 hours without (control; ) or with various () concentrations of
CBDCA (10 to 1000 mol/L), and uptake of FITC-albumin (30 g/mL)
for 30 minutes was measured at 37C. Each point is the mean 	 SE of
three monolayers. *P 
 0.05, significant difference from control.
Table 1. Effects of cis-diamminedichloroplatinum (II)
(CDDP) on lactate dehydrogenase (LDH) release
and cellular protein content in OK cells
concentrations of CBDCA, a second-generation plati-
LDH release Cellular protein
num with reduced clinical nephrotoxicity, on the uptake % of total activity lg/cm2 dish
of FITC-albumin in OK cells (Fig. 3). Pretreatment with Control 6.17	0.32 52.4	2.0
CBDCA for 24 hours induced a concentration-depen- CDDP 6.17	0.85 56.6	8.7
dent decrease in the uptake of FITC-albumin, but the Confluent monolayers of OK cells were pretreated for 24 hours without (con-
trol) or with CDDP (50 mol/L). Then, LDH activities in the medium and theconcentration-response curve for CBDCA shifted to the
cell lysate, and the cellular protein attached to the culture dish were measured.right compared with that for CDDP in Figure 2. The The rate of LDH release (% of total activity) was determined by dividing LDH
activity in the medium by total LDH activity. The total LDH activity was calcu-apparent IC50 of CBDCA for FITC-albumin uptake in
lated by adding LDH activity in medium to that in the cell lysate, and theirOK cells was 134.3 mol/L. In contrast to FITC-albumin values without or with CDDP were 0.75 	 0.01 and 0.76 	 0.01 IU/35 mm dish,
respectively. Each value is the mean 	 SE of three monolayers.uptake, the uptake of FITC-inulin, a marker for fluid-
phase endocytosis, was not significantly inhibited by the
pretreatment with CDDP at various concentrations (0.3
to 50 mol/L) for 24 hours (Fig. 4).
Influence of CDDP on kinetic parameters
of FITC-albumin uptakeCell viability of OK cells pretreated with CDDP
The effects of CDDP on the kinetic parameters ofTo confirm the specificity of the inhibitory effect of
FITC-albumin uptake were examined (Fig. 6). The kineticCDDP on the receptor-mediated endocytosis of albu-
constants of FITC-albumin uptake in OK cells were ana-min, the cell viability of OK cells pretreated with CDDP
lyzed by measuring the uptake of FITC-albumin over awas evaluated. As shown in Table 1, pretreatment of OK
concentration range of 30 to 500 g/mL. FITC-albumincells with 50 mol/L CDDP for 24 hours had no effect
uptake was saturable and inhibited by the CDDP pre-on LDH release into the medium and the amount of
treatment (50 mol/L, 24 hours) at all concentrations ofcellular protein attached to the culture plate. In addition,
FITC-albumin examined (Fig. 6A). Eadie-Hofstee plotsintracellular ATP content was not significantly affected
were linear in control and CDDP-treated cells (Fig. 6B).by CDDP pretreatment for 24 hours at various concen-
trations (Fig. 5). The Michaelis constants (Km) in the cells incubated with-
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Fig. 5. Effects of CDDP on intracellular ATP content in OK cells.
Confluent monolayers of OK cells were incubated for 24 hours without
() or with () various concentrations of CDDP (0.2 to 50 mol/L),
and ATP content in OK cells was measured. Each point is the mean 	
SE of three to six monolayers.
Fig. 6. Influence of CDDP on kinetic parameters of FITC-albumin
uptake in OK cells. Confluent monolayers of OK cells were incubated
out and with CDDP were 13.3 	 3.5 and 22.0 	 6.2 for 24 hours without () or with () CDDP (50 mol/L), and uptake
of FITC-albumin at various concentrations (10, 30, 50, 100, 300, andg/mL, and maximum uptake rates (Vmax) in the cells
500 g/mL) for 30 minutes was measured at 37C (A). Each point isincubated without and with CDDP were 5.5 	 0.6 and the mean 	 SE of four to five monolayers. (B) Eadie-Hofstee plots of
3.2 	 0.7 g/mg protein/30 min, respectively (means 	 the data from a typical experiment. Abbreviations are: V, initial uptake
rate; V/S, initial uptake rate per initial concentration.SE of 5 experiments). Thus, CDDP caused a decrease
in the affinity as well as in the maximal velocity of FITC-
albumin uptake in OK cells, indicating that the inhibition
is apparently a mixed-type, which has been observed
in OK cells was not changed up to day 5 after 10 mol/Lalso in the OK cells pretreated with bafilomycin A1, a CDDP pretreatment for 24 hours (day 0, 53.1 	 1.3;vacuolar H-ATPase inhibitor [13, 14].
day 1, 62.3 	 17.2; day 3, 58.0 	 1.4; day 5, 54.5 	 2.2%To examine whether CDDP pretreatment induces the
of control, mean 	 SE of 3 monolayers). Like CDDP,endosomal alkalinization in OK cells, endosomal pH
100 mol/L CBDCA pretreatment for 24 hours showedwas measured in OK cells pretreated without or with
no recovery of the inhibition of FITC-albumin uptake50 mol/L CDDP for 24 hours. Incubation with CDDP
up to day 5 after removal of CBDCA (day 0, 61.5 	 1.9;increased the endosomal pH from 6.61 	 0.14 to 6.92 	
day 1, 55.5 	 2.5; day 3, 53.5 	 5.1; day 5, 56.8 	 2.2%0.16 in OK cells (mean 	 SE of 5 monolayers). On the
of control, mean 	 SE of 4 monolayers).other hand, unlike CDDP, we were not able to detect
the endosomal alkalinization in OK cells pretreated with
Effects of CDDP and CBDCA administration300 mol/L CBDCA for 24 hours (control, 6.54 	 0.17;
on urinary excretion of albumin andCBDCA-pretreated, 6.42 	 0.08, mean 	 SE of 5 to 6
vitamin D binding protein in ratsmonolayers).
In vitro observations in OK cells suggest that CDDP
FITC-albumin uptake in OK cells administration affects the receptor-mediated endocyto-
after removal of CDDP or CBDCA sis of protein in the renal proximal tubules, which would
induce proteinuria. Therefore, to test this premise underWe examined whether CDDP- or CBDCA-induced
in vivo conditions, we examined the effect of CDDP ad-inhibition of FITC-albumin uptake in OK cells was re-
versible. The inhibitory effect on FITC-albumin uptake ministration on the urinary excretion of albumin in rat.
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Fig. 8. Effects of intraperitoneal CDDP administration on urinary ex-
cretion of vitamin D binding protein (DBP). Urine for 24 hours was
collected at day 1, day 3, day 5, day 7, day 10, and day 14 after the
intraperitoneal administration of saline in a normal rat (A) or 5 mg/kg
CDDP-treated rat (B). Urine was dialyzed and concentrated by freeze-
drying. The samples from urine (equivalent to the volume excreted for
6 min per lane) were subjected to 10% SDS-PAGE. The proteins were
blotted on a PVDF membrane and were detected by Western blotting.
An increase in BUN values, which were observed at
day 3 after the intraperitoneal administration of CDDP,
continued until day 14 (Fig. 7A). Urinary excretion of
NAG also increased and its peak was observed at day
7 after CDDP administration (Fig. 7B). The urinary ex-
cretion of albumin reached a maximum three days after
a bolus administration of CDDP (Fig. 7C). We also inves-
tigated the urinary excretion of vitamin D binding pro-
tein, a substrate for megalin that is an apical receptor
to endocytose a broad range of filtered plasma proteins,
in normal and CDDP-administered rats. Essentially, no
vitamin D binding protein was detected in each urine
sample from normal rats administered saline (Fig. 8A).
Fig. 7. Effects of intraperitoneal CDDP administration on BUN (A), In contrast to normal rats, a bolus administration ofand urinary excretion of NAG (B) and albumin (C ). Blood samples
CDDP induced a remarkable increase in urinary excre-were obtained at day 0 (before CDDP administration; ), day 3, day 7,
and day 14 after the intraperitoneal administration of CDDP (5 mg/kg; tion of vitamin D binding protein. The urinary excretion
). Urine for 24 hours was collected at day 0, day 1, day 3, day 5, day of vitamin D binding protein was highest three days after7, day 10, day 14, day 18, and day 21 after the administration of CDDP.
the bolus injection of CDDP, as is the case with albuminBUN and the total quantity of NAG and albumin in the urine were
measured as described in the Methods section. Each point is the mean	 in Figure 7C, and vitamin D binding protein in urine
SE of three to six experiments. was detected up to 14 days (Fig. 8B). Optical densities for
vitamin D binding protein band evaluated from separate
experiments were 23.7 	 22.2 (day 1), 2011.3 	 275.4
(day 3), 1370.0 	 121.7 (day 5), 973.0 	 66.0 (day 7),
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Fig. 9. Effects of intraperitoneal CBDCA administration on urinary
excretion of DBP. Urine for 24 hours was collected at day 0, day 1,
day 3, day 5, and day 7 after the intraperitoneal administration of
CBDCA (80 mg/kg). Urine was dialyzed and concentrated by freeze-
drying. The detection of urinary DBP was performed as described in
Fig. 8.
and 571.7 	 178.7 (day 14), respectively (mean 	 SE of
3 experiments).
Effects of CBDCA administration on urinary excre-
tion of vitamin D binding protein and albumin also were
examined. A bolus administration of CBDCA caused
increase in the urinary excretion of vitamin D binding
protein, but the increase was observed at day 5 or later
after CBDCA administration (Fig. 9). A similar pattern
was observed in the urinary excretion of albumin after
CBDCA administration (day 0, 0.48; day 1, 0.52; day 5,
3.0; day 7, 37.0 mg/day, N  2).
ATP content and megalin and ClC-5 levels
in renal cortex after CDDP administration
Effects of CDDP administration on ATP concentra-
tion in the renal cortex and megalin and ClC-5 expression
levels in crude membrane fractions of the renal cortex
were examined. ATP content in the renal cortex from Fig. 10. Expression levels of megalin and ClC-5 in crude membrane
fractions of rat renal cortex after CDDP administration. At day 0 (con-rats 3 days after CDDP administration was not reduced
trol), day 3, day 7, and day 14 after the intraperitoneal injection of(control, 1.58 	 0.04 mol/g cortex; CDDP-treated, CDDP (5 mg/kg), the levels of megalin (A) and ClC-5 (B) in the crude
1.87 	 0.09 mol/g cortex, mean 	 SE, N  3). CDDP membrane fractions of the renal cortex were measured by Western blot
analysis. Optical density for each band was determined by the publicadministration induced a transient increase in the expres-
domain program, NIH Image. Each column is the mean 	 SE of threesion level of megalin, which is one of the most important experiments.
endocytic receptors for the reabsorption of filtered pro-
teins and peptides (Fig. 10A). The expression level of
ClC-5, an important chloride channel that maintains and
recently found that CDDP inhibits vacuolar H-ATPasegenerates endosomal acidification, was not decreased by
in the renal brush-border membrane [18]. Vacuolar H-the administration of CDDP (Fig. 10B).
ATPase also is localized in the endosomal membrane,
and is responsible for lowering pH inside the endosome,
DISCUSSION which is an essential process for the dissociation of li-
The receptor-mediated endocytosis in the renal proxi- gands and receptors after receptor-mediated endocyto-
mal tubules has a crucial role in reabsorption of plasma sis. Thus, inhibition of vacuolar H-ATPase by CDDP
proteins filtered by the glomerulus. Therefore, protein- administration may lead to a decreased activity of the
uria induced by the administration of CDDP may be receptor-mediated endocytosis, resulting in proteinuria.
due to decrease in the activity of the receptor-mediated Our study analyzed the effects of CDDP on the receptor-
endocytosis in the renal proximal tubules. However, to mediated endocytosis of proteins in the kidney in vitro
our knowledge, the mechanism by which CDDP adminis- and in vivo.
Pretreatment with 50 mol/L CDDP led to a time-tration induces proteinuria has not been clarified. We
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dependent decrease in the receptor-mediated endocyto- OK cells. In addition, the uptake of inulin by the fluid-
phase endocytosis, a non-specific endocytic process thatsis of albumin in OK cells (Fig. 1). The significant inhibi-
tory effect was observed at 12 hours or later. Also, under is also ATP-dependent [34], was not significantly affected
by the CDDP pretreatment (Fig. 4). No change was ob-in vivo conditions, urinary excretion of albumin and vita-
min D binding protein reached a peak three days after served in the release of LDH and the amount of cellular
protein by the pretreatment with CDDP (Table 1), indi-a bolus administration of CDDP to rats (Figs. 7C and
8). Daugaard et al reported that the urinary excretion cating that general cytotoxicity has not been induced in
the OK cells under our experimental conditions. Thus,rates of total protein and albumin reached a maximum
around three to four days after the termination of CDDP CDDP decreased the activity of the receptor-mediated
endocytosis without decreasing ATP content and cellinfusion to cancer patients [9]. Thus, the CDDP-induced
decrease in the activity of receptor-mediated endocytosis viability.
CDDP caused decreases in the affinity as well as in thecould occur later, compared to the renal accumulation
of CDDP with a peak within several hours after the bolus maximal velocity of the receptor-mediated endocytosis of
albumin in OK cells (Fig. 6). We recently observed similaradministration of the drug [28]. The delayed inhibitory
effect may be dependent on the rate of CDDP transfor- mixed-type inhibition of receptor-mediated endocytosis
of albumin in OK cells pretreated with inhibitors on vacu-mation through aquation reactions, which are promoted
by intracellular low chloride ion concentration and forms olar H-ATPase (bafilomycin A1) and on chloride chan-
nel [5-nitro-2-(3-phenylpropylamino)-benzoic acid, NPPB]the hydrated derivatives of CDDP highly reactive for
biological nucleophiles such as sulfhydryl groups [8]. [14]. Vacuolar H-ATPase and chloride channel are the
components of the acidification machinery in endosomalNot only CDDP, but also CBDCA, a platinum com-
plex with reduced clinical nephrotoxicity compared to membrane. In addition, the endosomal pH was increased
from 6.61 	 0.14 to 6.92 	 0.16 by the pretreatment withCDDP, inhibited the receptor-mediated endocytosis of
albumin in a concentration-dependent manner in OK CDDP. The change in endosomal pH by CDDP (pH 
0.31) seems to be sufficient to reduce the receptor-medi-cells (Figs. 2 and 3). However, the apparent IC50 value of
CBDCA (134.3 mol/L) was more than 10 times higher, ated endocytosis in OK cells, because even high concen-
tration of bafilomycin A1 (1 mol/L), which is enoughcompared with that of CDDP (11.3 mol/L). In addition,
a bolus administration of CDDP and CBDCA increased to suppress receptor-mediated endocytosis almost com-
pletely, increased the endosomal pH by about 0.5 [13].the urinary excretion of albumin and vitamin D binding
protein in rats, though CBDCA caused the increase in These findings suggest that CDDP-induced inhibition
of the receptor-mediated endocytosis is related to thethe urinary excretion of these proteins later than CDDP
by several days (Fig. 9). The delay in CBDCA effect would impairment of the acidification machinery. Especially,
vacuolar H-ATPase is a most likely target molecule in-not be due to the differences in their pharmacokinetics,
because both CDDP and CBDCA are excreted rapidly volved in CDDP-induced decrease in the receptor-medi-
ated endocytosis, as we demonstrated the inhibition ofinto the urine. Reportedly, rats receiving CBDCA excretes
about 90% of the dose into the urine in four hours [29]. vacuolar H-ATPase activity by CDDP [18]. However,
the endosomal alkalinization by CDDP also may be re-There are some reports showing the differences in the
potencies of biological activities between CDDP and lated to decrease in the activity of ClC-5, which plays
an important role in the maintenance of electroneutralityCBDCA. Courjault-Gautier et al have shown that CBDCA
induced alterations of sodium-coupled uptake by rabbit and the generation of the proton gradient in endosome,
though that hypothesis remains to be examined.proximal tubule cells at concentrations 20 to 30 times
higher than CDDP [30]. Micetich, Barnes and Erick- Megalin, a member of the low-density lipoprotein re-
ceptor gene family, plays an important role in endocyticson also reported that CBDCA is approximately 45-fold
less cytotoxic than CDDP against L1210 cells [31]. Since uptake of proteins filtered through the glomerulus as
well as of some polybasic drugs [22, 35, 36]. Megalin inKnox et al have reported that the hydrated derivatives
of CBDCA was formed 112-fold more slowly than those the renal proximal tubules also may be responsible for
the reabsorption of vital substances such as vitaminsof CDDP [32], such a slow rate of aquation for CBDCA
may be related to various differences observed between (vitamin D3, vitamin A and vitamin B12) from the tubular
fluid [36, 37]. Using a megalin knockout mouse, it wasCDDP and CBDCA.
The receptor-mediated endocytosis is an ATP-depen- demonstrated that complexes of 25-hydroxyvitamin D3
and vitamin D binding protein are continuously filtereddent process, and is inhibited by various metabolic inhibi-
tors such as 2,4-dinitrophenol and sodium azide [33]. through the glomerulus and reabsorbed by the megalin-
mediated endocytosis in the proximal tubules [21]. InTherefore, we examined whether CDDP pretreatment
affects the intracellular ATP concentration in OK cells. the present study, CDDP and CBDCA administration
induced a remarkable increase in the urinary excretionAs shown in Figure 5, pretreatment with CDDP at vari-
ous concentrations had little effect on ATP content in of vitamin D binding protein, probably due to the inhibi-
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